Tidal Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-750
Closed -$48K 1961
2024
Q4
$48K Buy
+750
New +$81.1K ﹤0.01% 1802

Other funds holding NVO

Tidal Investments's NVO Position: Q1 2026 in Review

Tidal Investments increased its Novo Nordisk (NVO) stake by 199% in Q1 2026, buying an estimated $2.41M and bringing the position to 76,545 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #1026.

Tidal Investments first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $7.28M in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Tidal Investments held 76,545 shares of Novo Nordisk worth $2.81M as of Q1 2026.
  • Tidal Investments bought 50,958 Novo Nordisk shares in Q1 2026, an estimated $2.41M.
  • Novo Nordisk made up 0.01% of Tidal Investments's portfolio in Q1 2026, its #1026 holding.
  • Tidal Investments first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • Tidal Investments's Novo Nordisk position peaked at $7.28M in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.